| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology, Pathobiology, and Genetics |
1 Departments of Otolaryngology and Immunology, 2 University of Pittsburgh Cancer Institute, Departments of 3 Surgery, 4 Pathology, and5 Biostatistics, University of Pittsburgh, Pittsburgh, Pennsylvania; and 6 Cepheid, Sunnyvale, California
Requests for reprints: Tony E. Godfrey, Mount Sinai School of Medicine, Box 1079, One Gustave L. Levy Place, New York, NY 10029. Phone: 212-659-9082; Fax: 212-828-4221; E-mail: tony.godfrey{at}mssm.edu or Robert L. Ferris, University of Pittsburgh Cancer Institute, Hillman Research Wing 1.19d, 5117 Centre Avenue, Pittsburgh, PA 15213. Phone: 412-623-7703; E-mail: ferrisrl{at}upmc.edu..
Clinical staging of cervical lymph nodes from patients with squamous cell carcinoma of the head and neck (SCCHN) has only 50% accuracy compared with definitive pathologic assessment. Consequently, both clinically positive and clinically negative patients frequently undergo neck dissections that may not be necessary. To address this potential overtreatment, sentinel lymph node (SLN) biopsy is currently being evaluated to provide better staging of the neck. However, to fully realize the potential improvement in patient care afforded by the SLN procedure, a rapid and accurate SLN analysis is necessary. We used quantitative reverse transcription–PCR (QRT-PCR) to screen 40 potential markers for their ability to detect SCCHN metastases to cervical lymph nodes. Seven markers were identified with good characteristics for identifying metastatic disease, and these were validated using a set of 26 primary tumors, 19 histologically positive lymph nodes, and 21 benign nodes from patients without cancer. Four markers discriminated between positive and benign nodes with accuracy >97% but only one marker, pemphigus vulgaris antigen (PVA), discriminated with 100% accuracy in both the observed data and a statistical bootstrap analysis. A rapid QRT-PCR assay for PVA was then developed and incorporated into a prototype instrument capable of performing fully automated RNA isolation and QRT-PCR. The automated analysis with PVA provided perfect discrimination between histologically positive and benign lymph nodes and correctly identified two lymph nodes with micrometastatic tumor deposits. These assays were completed (from tissue to result) in 
30 minutes, thus demonstrating the feasibility of intraoperative staging of SCCHN SLNs by QRT-PCR.
Key Words: molecular markers • head and neck/oral cancer • metastasis
This article has been cited by other articles:
|
|
 |
|
  M. Tomifuji, A. Shiotani, H. Fujii, K. Araki, K. Saito, K. Inagaki, M. Mukai, Y. Kitagawa, and K. Ogawa Sentinel Node Concept in Clinically N0 Laryngeal and Hypopharyngeal Cancer Ann. Surg. Oncol., September 1, 2008; 15(9): 2568 - 2575. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-H. Yuan, X.-F. Liang, W.-H. Jia, J.-L. Huang, M. Wei, L. Deng, L.-Z. Liang, X.-Y. Wang, and Y.-X. Zeng Molecular Diagnosis of Sentinel Lymph Node Metastases in Cervical Cancer Using Squamous Cell Carcinoma Antigen Clin. Cancer Res., September 1, 2008; 14(17): 5571 - 5578. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Xi, D. G. Nicastri, T. El-Hefnawy, S. J. Hughes, J. D. Luketich, and T. E. Godfrey Optimal Markers for Real-Time Quantitative Reverse Transcription PCR Detection of Circulating Tumor Cells from Melanoma, Breast, Colon, Esophageal, Head and Neck, and Lung Cancers Clin. Chem., July 1, 2007; 53(7): 1206 - 1215. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Shayan, M. G. Achen, and S. A. Stacker Lymphatic vessels in cancer metastasis: bridging the gaps Carcinogenesis, September 1, 2006; 27(9): 1729 - 1738. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Ferris, T. L. Whiteside, and S. Ferrone Immune Escape Associated with Functional Defects in Antigen-Processing Machinery in Head and Neck Cancer. Clin. Cancer Res., July 1, 2006; 12(13): 3890 - 3895. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Xi, M. C. Coello, V. R. Litle, S. Raja, W. E. Gooding, S. A. Yousem, T. El-Hefnawy, R. J. Landreneau, J. D. Luketich, and T. E. Godfrey A Combination of Molecular Markers Accurately Detects Lymph Node Metastasis in Non-Small Cell Lung Cancer Patients Clin. Cancer Res., April 15, 2006; 12(8): 2484 - 2491. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Garrel, M. Dromard, V. Costes, E. Barbotte, F. Comte, Q. Gardiner, C. Cartier, M. Makeieff, L. Crampette, B. Guerrier, et al. The Diagnostic Accuracy of Reverse Transcription-PCR Quantification of Cytokeratin mRNA in the Detection of Sentinel Lymph Node Invasion in Oral and Oropharyngeal Squamous Cell Carcinoma: A Comparison with Immunohistochemistry Clin. Cancer Res., April 15, 2006; 12(8): 2498 - 2505. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Lopez-Albaitero, J. V. Nayak, T. Ogino, A. Machandia, W. Gooding, A. B. DeLeo, S. Ferrone, and R. L. Ferris Role of Antigen-Processing Machinery in the In Vitro Resistance of Squamous Cell Carcinoma of the Head and Neck Cells to Recognition by CTL J. Immunol., March 15, 2006; 176(6): 3402 - 3409. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. G. Soltesz, S. Kim, S.-W. Kim, R. G. Laurence, A. M. De Grand, C. P. Parungo, L. H. Cohn, M. G. Bawendi, and J. V. Frangioni Sentinel Lymph Node Mapping of the Gastrointestinal Tract by Using Invisible Light Ann. Surg. Oncol., March 1, 2006; 13(3): 386 - 396. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Xi, W. Gooding, K. McCarty, T. E. Godfrey, and S. J. Hughes Identification of mRNA markers for molecular staging of lymph nodes in colorectal cancer. Clin. Chem., March 1, 2006; 52(3): 520 - 523. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
